Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFJ7C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,086
Award facts
- Contract value 100% obligated
- $11,085.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,085.57 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on December 29, 2025, with completion targeted for December 30, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The award is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability in delivering a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Dupixent, a biologic treatment for eczema and other inflammatory conditions, exemplifies the company's role in supplying specialized pharmaceutical commodities to support military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FFJ7C?
SPE2DR26FFJ7C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FFJ7C worth?
The government has obligated $11,086 on SPE2DR26FFJ7C.
Is contract SPE2DR26FFJ7C an order under another contract?
Yes. SPE2DR26FFJ7C is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFJ7C competed?
The extent of competition for SPE2DR26FFJ7C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award